Clinical Variant of Guillain-Barre Syndrome With Prominent Facial Diplegia After AstraZeneca Coronavirus Disease 2019 Vaccine.
J Clin Neuromuscul Dis
; 23(2): 115-116, 2021 Dec 01.
Article
in English
| MEDLINE | ID: covidwho-1528206
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Guillain-Barre Syndrome
/
Facial Paralysis
/
COVID-19
/
ChAdOx1 nCoV-19
Type of study:
Prognostic study
Topics:
Vaccines
/
Variants
Limits:
Female
/
Humans
/
Middle aged
Language:
English
Journal:
J Clin Neuromuscul Dis
Journal subject:
Physiology
/
Neurology
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS